Showing 368 results

Filters Content type: News, Editors' picks, About HIV Topic: Drug-resistant TB

Some strains of tuberculosis (TB) are resistant to several different drugs. Multidrug-resistant TB (MDR-TB) can usually be treated successfully after identifying which drugs the bacteria are still susceptible to. A strain of TB that is resistant to a larger number of drugs is known as extensively drug-resistant TB (XDR-TB).

Drug-resistant TB

Compassionate use of and expanded access to new drugs for drug-resistant tuberculosis

Editor's pick
Interrnational Journal of Tuberculosis and Lung Disease
11 January 2013
Drug-resistant TB

WHO to convene expert meeting on the use of bedaquiline for MDR-TB treatment

Editor's pick
Stop TB Partnership
8 January 2013
TB treatment

US Food and Drug Administration approves Sirturo (bedaquiline) to treat MDR TB in adults

Editor's pick
FDA
2 January 2013
Drug-resistant TB

Resistance to injectable second-line drugs in TB related to age, HIV status

Editor's pick
Healio
31 December 2012
Drug-resistant TB

Aggressive therapy for MDR-TB reduces risk of disease recurrence

News
31 December 2012
Drug-resistant TB

New tuberculosis drug trial begins in South Africa

Editor's pick
Eurekalert Medicine & Health
11 December 2012
Drug-resistant TB

FDA Advisory Committee recommends accelerated approval of bedaquiline for drug-resistant TB

News
3 December 2012
Drug-resistant TB

Treatment Action Group welcomes FDA review of first new tuberculosis drug in half a century

Editor's pick
Treatment Action Group
29 November 2012
Drug-resistant TB

New type of TB drug deemed safe by FDA

Editor's pick
MedPage Today
28 November 2012
Drug-resistant TB

How fight to tame TB made it stronger

Editor's pick
Wall Street Journal
24 November 2012
TB diagnosis

Xpert test for TB could help prevent deaths in southern Africa, but at substantial cost

Editor's pick
Eurekalert Inf Dis
21 November 2012
Drug-resistant TB

MSF: Implementation of new test increases drug-resistant TB diagnosis while shortening treatment initiation time

Editor's pick
Médecins Sans Frontières press release
15 November 2012
TB treatment

Structure discovered for promising tuberculosis drug target

Editor's pick
Eurekalert Inf Dis
26 October 2012
Drug-resistant TB

Capacity to diagnose M/XDR-TB strengthened across Europe

Editor's pick
WHO Europe
19 October 2012
TB diagnosis

As multidrug-resistant tuberculosis continues to spread, new efforts to coordinate TB detection and treatment hold promise

Editor's pick
TB Alliance
17 October 2012
TB treatment

Curing TB in Europe is more about politics than science

Editor's pick
BMJ blogs
11 October 2012
Drug-resistant TB

WHO and PATH publish updated MDR-TB Planning Toolkit

Editor's pick
Stop TB Partnership
5 October 2012
TB treatment

Launch of the Good Participatory Practice Guidelines for TB Drug Trials

Editor's pick
Critical Path to TB Drug Regimens
4 October 2012
Drug-resistant TB

TB drug trial yields gains in drug-resistant disease treatment

Editor's pick
Science Speaks
2 October 2012
Drug-resistant TB

In Romania, chance determines whether drug-resistant TB patients survive

Editor's pick
AlertNet
25 September 2012
TB treatment

Sanofi and TB Alliance Announce Collaboration to Accelerate New Treatments Against Tuberculosis

Editor's pick
TB Alliance
21 September 2012
Drug-resistant TB

Oxyphenbutazone can kill drug resistant TB

Editor's pick
News-Medical Net
11 September 2012
Drug-resistant TB

HIV is a risk factor for acquired resistance to key second-line anti-TB drugs

News
6 September 2012
Drug-resistant TB

Janssen-Cilag International NV (Janssen) Submits European Marketing Authorisation Application for Investigational Multi-Drug Resistant Tuberculosis Treatment Bedaquiline

Editor's pick
Janssen-Cilag press release
3 September 2012